Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial

NCT01799486 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

HBV-related Liver Cirrhosis

Interventions

DRUG: Telbivudine
DRUG: Enecavir
DRUG: Adefovir

Sponsor

Lin Bingliang

Collaborators

[object Object]